Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 4561 AL 4575

Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study

Leonpacher AK, Peters ME, Drye LT, Makino KM, Newell JA, Devanand DP, Frangakis C, Munro CA, Mintzer JE, Pollock BG, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Porsteinsson AP; CitAD Research Group.

Am J Psychiatry. 2016 May 1;173(5):473-80. doi: 10.1176/appi.ajp.2016.15020248. Epub 2016 Apr 1.

My Mind Project: the effects of cognitive training for elderly-the study protocol of a prospective randomized intervention study

Giuli C, Fattoretti P, Gagliardi C, Mocchegiani E, Venarucci D, Balietti M, Casoli T, Costarelli L, Giacconi R, Malavolta M, Papa R, Lattanzio F, Postacchini D.

Aging Clin Exp Res. 2017 Jun;29(3):353-360. doi: 10.1007/s40520-016-0570-1. Epub 2016 Apr 22.

Adrenergic Drugs Blockers or Enhancers for Cognitive Decline ? What to Choose for Alzheimer's Disease Patients?

Femminella GD, Leosco D, Ferrara N, Rengo G.

CNS Neurol Disord Drug Targets. 2016;15(6):665-71. doi: 10.2174/1871527315666160518123201.

Non-Demented Individuals with Alzheimer's Disease Neuropathology: Resistance to Cognitive Decline May Reveal New Treatment Strategies

Zolochevska O, Taglialatela G.

Curr Pharm Des. 2016;22(26):4063-8. doi: 10.2174/1381612822666160518142110.

The Rationale for Insulin Therapy in Alzheimer's Disease

Ribarič S.

Molecules. 2016 May 26;21(6):689. doi: 10.3390/molecules21060689.

Identifying and Managing Pain in People with Alzheimer's Disease and Other Types of Dementia: A Systematic Review

Husebo BS, Achterberg W, Flo E.

CNS Drugs. 2016 Jun;30(6):481-97. doi: 10.1007/s40263-016-0342-7.

Current pharmacotherapy and putative disease-modifying therapy for Alzheimer's disease

Kulshreshtha A, Piplani P.

Neurol Sci. 2016 Sep;37(9):1403-35. doi: 10.1007/s10072-016-2625-7. Epub 2016 Jun 1.

Improving Memory and Cognition in Individuals with Down Syndrome

Rafii MS.

CNS Drugs. 2016 Jul;30(7):567-73. doi: 10.1007/s40263-016-0353-4.

Improving Prospective Memory in Healthy Older Adults and Individuals with Very Mild Alzheimer's Disease

Shelton JT, Lee JH, Scullin MK, Rose NS, Rendell PG, McDaniel MA.

J Am Geriatr Soc. 2016 Jun;64(6):1307-12. doi: 10.1111/jgs.14134.

Antihypertensiva-Stopp ohne Effekt auf die kognitive Funktion alter Menschen

Zechmann S.

Praxis (Bern 1994). 2016 Jul;105(15):917-8. doi: 10.1024/1661-8157/a002417.

Therapies for Prevention and Treatment of Alzheimer's Disease

Mendiola-Precoma J, Berumen LC, Padilla K, Garcia-Alcocer G.

Biomed Res Int. 2016;2016:2589276. doi: 10.1155/2016/2589276. Epub 2016 Jul 28.

Drug use in persons with and without Alzheimer's disease aged 90 years or more

Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S.

Age Ageing. 2016 Nov;45(6):900-904. doi: 10.1093/ageing/afw141. Epub 2016 Sep 8.

Cognitive Impairment, Alzheimer's Disease, and Other Dementias in the Lives of Lesbian, Gay, Bisexual and Transgender (LGBT) Older Adults and Their Caregivers: Needs and Competencies

Fredriksen-Goldsen KI, Jen S, Bryan AEB, Goldsen J.

J Appl Gerontol. 2018 May;37(5):545-569. doi: 10.1177/0733464816672047. Epub 2016 Oct 10.

Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease

Cavedo E, Dubois B, Colliot O, Lista S, Croisile B, Tisserand GL, Touchon J, Bonafe A, Ousset PJ, Rouaud O, Ricolfi F, Vighetto A, Pasquier F, Galluzzi S, Delmaire C, Ceccaldi M, Girard N, Lehericy S, Duveau F, Chupin M, Sarazin M, Dormont D, Hampel H; Hippocampus Study Group.

J Clin Psychiatry. 2016 Dec;77(12):e1631-e1638. doi: 10.4088/JCP.15m10413.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias